MedinCell S.A.
MEDCL.PA · PAR
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | €11,608 | €16,106 | €9,435 | €3,765 |
| % Growth | -27.9% | 70.7% | 150.6% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €329 |
| Gross Profit | €0 | €16,106 | €9,435 | €3,436 |
| % Margin | 0% | 100% | 100% | 91.3% |
| R&D Expenses | €12,527 | €14,041 | €10,277 | €9,920 |
| G&A Expenses | €0 | €5,887 | €5,030 | €4,567 |
| SG&A Expenses | €7,284 | €7,460 | €6,716 | €5,797 |
| Sales & Mktg Exp. | €0 | €1,573 | €1,686 | €1,230 |
| Other Operating Expenses | €0 | €102 | -€29 | €44 |
| Operating Expenses | €19,811 | €21,603 | €16,964 | €15,761 |
| Operating Income | -€9,149 | -€3,311 | -€7,529 | -€11,996 |
| % Margin | -78.8% | -20.6% | -79.8% | -318.6% |
| Other Income/Exp. Net | -€9,436 | -€528 | -€6,910 | -€4,796 |
| Pre-Tax Income | -€18,585 | -€3,839 | -€14,439 | -€16,792 |
| Tax Expense | -€2,507 | €31 | €129 | €88 |
| Net Income | -€16,078 | -€3,870 | -€14,568 | -€16,880 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS | -0.49 | -0.12 | -0.5 | -0.58 |
| % Growth | -308.3% | 76% | 13.8% | – |
| EPS Diluted | -0.49 | -0.12 | -0.5 | -0.58 |
| Weighted Avg Shares Out | 33,084 | 31,835 | 29,101 | 28,891 |
| Weighted Avg Shares Out Dil | 33,084 | 31,835 | 29,101 | 28,974 |
| Supplemental Information | – | – | – | – |
| Interest Income | €804 | €657 | €0 | €794 |
| Interest Expense | €2,842 | €2,567 | €1,774 | €4,438 |
| Depreciation & Amortization | €946 | €1,651 | €339 | €432 |
| EBITDA | -€14,797 | -€3,941 | -€7,259 | -€11,551 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |